Search Results - "DESABLENS, Bernard"

A Randomized Comparison of All Transretinoic Acid (ATRA) Followed by Chemotherapy and ATRA Plus Chemotherapy and the Role of Maintenance Therapy in Newly Diagnosed Acute Promyelocytic Leukemia by Fenaux, Pierre, Chastang, Claude, Chevret, Sylvie, Sanz, Miguel, Dombret, Hervé, Archimbaud, Eric, Fey, Martin, Rayon, Consuelo, Huguet, Françoise, Sotto, Jean-Jacques, Gardin, Claude, Makhoul, Pascale Cony, Travade, Philippe, Solary, Eric, Fegueux, Nathalie, Bordessoule, Dominique, Miguel, Jesus San, Link, Harmut, Desablens, Bernard, Stamatoullas, Aspasia, Deconinck, E., Maloisel, Fréderic, Castaigne, Sylvie, Preudhomme, Claude, Degos, Laurent

“…All transretinoic acid (ATRA) followed by daunorubicin (DNR)-AraC chemotherapy (CT) has improved the outcome of acute promyelocytic leukemia (APL) by…”
Get full text

Chlorambucil in Indolent Chronic Lymphocytic Leukemia by Dighiero, Guillaume, Maloum, Karim, Desablens, Bernard, Cazin, Bruno, Navarro, Maurice, Leblay, Robert, Leporrier, Michel, Jaubert, Jérome, Lepeu, Gérard, Dreyfus, Brigitte, Binet, Jacques-Louis, Travade, Philippe, Turpin, François-Louis, Tertian, Gérard, Bichoffe, Agnès

“…Many patients with chronic lymphocytic leukemia (CLL) have long lives and die of causes unrelated to the disease. 1 , 2 Rai's classification 3 – 5 and Binet's…”
Get full text

Primary central nervous system lymphomas in 72 immunocompetent patients : Pathologic findings and clinical correlations by CAMILLERI-BROËT, S, MARTIN, A, MOKHTARI, K, MORCOS, M, BROËT, P, KUJAS, M, HAUW, J.-J, DESABLENS, B, RAPHAËL, M, MOREAU, A, ANGONIN, R, HENIN, D, GONTIER, M. F, ROUSSELET, M. C, CAULET-MAUGENDRE, S, CUILLIERE, P, LEFRANCQ, T

Get full text

Upfront VIP‐reinforced‐ABVD (VIP‐rABVD) is not superior to CHOP/21 in newly diagnosed peripheral T cell lymphoma. Results of the randomized phase III trial GOELAMS‐LTP95 by Simon, Audrey, Peoch, Michel, Casassus, Philippe, Deconinck, Eric, Colombat, Philippe, Desablens, Bernard, Tournilhac, Olivier, Eghbali, Houchingue, Foussard, Charles, Jaubert, Jerome, Vilque, Jean Pierre, Rossi, Jean François, Lucas, Virginie, Delwail, Vincent, Thyss, Antoine, Maloisel, Frederic, Milpied, Noel, Le Gouill, Steven, Lamy, Thierry, Gressin, Rémy

“…Summary Peripheral T‐Cell lymphomas (PTCL) are relatively rare diseases but appear to be highly aggressive and display worse remission and survival rates than…”
Get full text

High-dose therapy followed by autologous purged stem cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by the GOELAMS with final results after a median follow-up of 9 years by Gyan, Emmanuel, Foussard, Charles, Bertrand, Philippe, Michenet, Patrick, Le Gouill, Steven, Berthou, Christian, Maisonneuve, Hervé, Delwail, Vincent, Gressin, Rémi, Quittet, Philippe, Vilque, Jean-Pierre, Desablens, Bernard, Jaubert, Jérôme, Ramée, Jean-François, Arakelyan, Nina, Thyss, Antoine, Moluçon-Chabrot, Cécile, Delépine, Roselyne, Milpied, Noël, Colombat, Philippe, Deconinck, Eric

“…Autologous stem cell transplantation (ASCT) as first-line therapy for follicular lymphoma (FL) remains controversial. The multicenter study randomized 172…”
Get full text

High-dose therapy followed by autologous purged stem-cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by GOELAMS by Deconinck, Eric, Foussard, Charles, Milpied, Noel, Bertrand, Philippe, Michenet, Patrick, Cornillet-LeFebvre, Pascale, Escoffre-Barbe, Martine, Maisonneuve, Herve, Delwail, Vincent, Gressin, Remy, Legouffe, Eric, Vilque, Jean-Pierre, Desablens, Bernard, Jaubert, Jerome, Ramee, Jean-François, Jenabian, Arash, Thyss, Antoine, Le Pourhiet-Le Mevel, Annick, Travade, Philippe, Delepine, Roselyne, Colombat, Philippe

“…Doxorubicin-based immunochemotherapy, with interferon, has been shown to improve survival in patients with advanced follicular lymphoma. High-dose chemotherapy…”
Get full text

Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients by Leporrier, Michel, Chevret, Sylvie, Cazin, Bruno, Boudjerra, Najda, Feugier, Pierre, Desablens, Bernard, Rapp, Marie-José, Jaubert, Jerome, Autrand, Claudie, Divine, Marine, Dreyfus, Brigitte, Maloum, Karim, Travade, Philippe, Dighiero, Guillaume, Binet, Jacques-Louis, Chastang, Claude

“…To comparatively assess first-line treatment with fludarabine and 2 anthracycline-containing regimens, namely CAP (cyclophosphamide, doxorubicin plus…”
Get full text

A Randomized Comparison of All Transretinoic Acid (ATRA) Followed by Chemotherapy and ATRA Plus Chemotherapy and the Role of Maintenance Therapy in Newly Diagnosed Acute Promyelocytic Leukemia by Fenaux, Pierre, Chastang, Claude, Chevret, Sylvie, Sanz, Miguel, Dombret, Hervé, Archimbaud, Eric, Fey, Martin, Rayon, Consuelo, Huguet, Françoise, Sotto, Jean-Jacques, Gardin, Claude, Makhoul, Pascale Cony, Travade, Philippe, Solary, Eric, Fegueux, Nathalie, Bordessoule, Dominique, Miguel, Jesus San, Link, Harmut, Desablens, Bernard, Stamatoullas, Aspasia, Deconinck, E., Maloisel, Fréderic, Castaigne, Sylvie, Preudhomme, Claude, Degos, Laurent

“…All transretinoic acid (ATRA) followed by daunorubicin (DNR)-AraC chemotherapy (CT) has improved the outcome of acute promyelocytic leukemia (APL) by…”
Get full text

Reduced Versus Full Doses of Irradiation After 3 Cycles of Combined Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine in Early Stage Hodgkin Lymphomas: Results of a Randomized Trial by ARAKELYAN, Nina, JAIS, Jean-Philippe, DELWAIL, Vincent, BRIERE, Josette, MOLES-MOREAU, Marie-Pierre, SENECAL, Delphine, BERTHOU, Christian, DESABLENS, Bernard, COLONNA, Pierre, ANDRIEU, Jean-Marie

“…The combination of 3 cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) and a tailored, extended irradiation schedule has been used to treat…”
Get full text

Reduced versus full doses of irradiation after 3 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine in early stage Hodgkin lymphomas by Arakelyan, Nina, Jais, Jean‐Philippe, Delwail, Vincent, Brière, Josette, Moles‐Moreau, Marie‐Pierre, Sénécal, Delphine, Berthou, Christian, Desablens, Bernard, Colonna, Pierre, Andrieu, Jean‐Marie

“…BACKGROUND: The combination of 3 cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) and a tailored, extended irradiation schedule has been…”
Get full text

Early Versus Late Intensification for Patients With High-Risk Hodgkin Lymphoma-3 Cycles of Intensive Chemotherapy Plus Low-Dose Lymph Node Radiation Therapy Versus 4 Cycles of Combined Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine Plus Myeloablative Chemotherapy With Autologous Stem Cell Transplantation Five-Year Results of a Randomized Trial on Behalf of the GOELAMS Group by ARAKELYAN, Nina, BERTHOU, Christian, DESABLENS, Bernard, DE GUIBERT, Sophie, DELWAIL, Vincent, MOLES, Marie-Pierre, QUITTET, Philippe, JAIS, Jean-Philippe, COLONNA, Pierre, ANDRIEU, Jean-Marie

“…The 5-year freedom from treatment failure (FFTF) rate, with treatment failure defined as the lack of post-treatment complete remission (CR), recurrence, or…”
Get full text

Comparison of autologous bone marrow transplantation and intensive chemotherapy as postremission therapy in adult acute myeloid leukemia by HAROUSSEAU, J.-L, CAHN, J.-Y, CAILLOT, D, ABGRALL, J.-F, FRANCOIS, S, BRIERE, J, GUYOTAT, D, CASASSUS, P, AUDHUY, B, TELLIER, Z, HURTELOUP, P, HERVE, P, PIGNON, B, WITZ, F, MILPIED, N, DELAIN, M, LIOURE, B, LAMY, T, DESABLENS, B, GUILHOT, F

Get full text

Intermediate stage Hodgkin lymphoma in partial remission after three or four courses of doxorubicin, bleomycin, vinblastine dacarbazine: no benefit of one course of intensive chemotherapy before irradiation by Arakelyan, Nina, Jais, Jean-Philippe, Tomowiack, Cécile, Colombat, Philippe, Berthou, Christian, Desablens, Bernard, Moles-Moreau, Marie-Pierre, Gastinne, Thomas, Quittet, Philippe, Casassus, Philippe, Le Pourhiet-Le Mevel, Annick, Ghandour, Christiane, Brière, Josette, Colonna, Pierre, Andrieu, Jean-Marie

“…The H97-I trial (1997-2004) for Hodgkin lymphoma at intermediate stage (HL-I) included 269 patients who were randomized to receive three or four cycles of…”
Get full text

Multicenter, randomized comparative trial of fludarabine and the combination of cyclophosphamide-doxorubicin-prednisone in 92 patients with Waldenström macroglobulinemia in first relapse or with primary refractory disease by Leblond, Véronique, Lévy, Vincent, Maloisel, Frédéric, Cazin, Bruno, Fermand, Jean-Paul, Harousseau, Jean-Luc, Remenieras, Liliane, Porcher, Raphaël, Gardembas, Martine, Marit, Gérald, Deconinck, Eric, Desablens, Bernard, Guilhot, François, Philippe, Guilaine, Stamatoullas, Aspasia, Guibon, Odile

“…Few reports are available on the treatment of patients with Waldenström macroglobulinemia (WM) and primary or secondary resistance to alkylating-agent–based…”
Get full text

Early versus late intensification for patients with high‐risk Hodgkin lymphoma—3 Cycles of intensive chemotherapy plus low‐dose lymph node radiation therapy versus 4 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine plus myeloablative chemotherapy with autologous stem cell transplantation by Arakelyan, Nina, Berthou, Christian, Desablens, Bernard, de Guibert, Sophie, Delwail, Vincent, Moles, Marie‐Pierre, Quittet, Philippe, Jais, Jean‐Philippe, Colonna, Pierre, Andrieu, Jean‐Marie

“…BACKGROUND. The 5‐year freedom from treatment failure (FFTF) rate, with treatment failure defined as the lack of post‐treatment complete remission (CR),…”
Get full text

Comparison of initial characteristics and long-term outcome of patients with lymphocyte-predominant Hodgkin lymphoma and classical Hodgkin lymphoma at clinical stages IA and IIA prospectively treated by brief anthracycline-based chemotherapies plus extended high-dose irradiation by Feugier, Pierre, Labouyrie, Eric, Djeridane, Malika, Jenabian, Arash, Dubruille, Viviane, Berthou, Christian, Ghandour, Christiane, Desablens, Bernard, Chaït, Yasmine, Casassus, Philippe, Delwail, Vincent, Ifrah, Norbert, Le Mevel, Annick, Lamy, Thierry, Brière, Josette, Colonna, Pierre, Andrieu, Jean-Marie

“…Lymphocyte-predominant Hodgkin lymphoma (LPHL), according to the Revised European-American Lymphoma classification, was considered on a retrospective basis as…”
Get full text

Long-Term Prognostic Value of Hematological and “Old” Biological Parameters in CLL. Reflexions on 156 Patients with a Median Follow-Up Time More Than 6.5 Years by Garidi, Réda, Vaida, Ioana, Capiod, Jean-Claude, Idris, Salhia Sid, Desablens, Bernard

“…Waiting for a standardization of “modern” biological prognostic factors in CLL, such as mutational status, ZAP-protein, CD38… we review with a long median…”
Get full text

Re-Evaluation of Prognostic Value of Seric LDH and β2-Microglobulin Levels among 248 CLL with a Median Follow-Up Time More Than 6 Years by Desablens, Bernard, Garidi, Réda, Gruson, Bérengère, Vaida, Iona, Brevet, Marie

“…Except in MD Anderson Center, seric β2-m is not recognized as a strong prognostic factor in CLL and seric LDH too, despite this factor is more and more…”
Get full text

Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis : results of APL 93 trial by DE BOTTON, Stéphane, CHEVRET, Sylvie, GARDIN, Claude, MAKHOUL, Pascale Cony, TRAVADE, Philippe, SOLARY, Eric, FEGUEUX, Nathalie, BORDESSOULE, Dominique, SAN MIGUEL, Jesus, LINK, Harmut, DESABLENS, Bernard, STAMATOULLAS, Aspasia, SANZ, Miguel, DECONINCK, Fric, GEISER, K, HESS, U, MALOISEL, Fréderic, CASTAIGNE, Sylvie, PREUDHOMME, Claude, CHOMIENNE, Christine, DEGOS, Laurent, FENAUX, Pierre, DOMBRET, Hervé, THOMAS, Xavier, GUERCI, Agnès, FEY, Martin, RAYON, Consuelo, HUGUET, Francoise, SOTTO, Jean-Jacques

“…In spite of the recent improvement in the outcome of acute promyelocytic leukaemia (APL) with treatment combining all trans retinoic acid (ATRA) and…”
Get full text

Stage I-IIE Primary Non-Hodgkin's Lymphoma of the Testis: Results of a Prospective Trial by the GOELAMS Study Group by Linassier, Claude, Desablens, Bernard, Lefrancq, Thierry, Le Prise, Pierre-Yves, Harousseau, Jean-Luc, Jacob, Claude, Gandhour, Christine, Haillot, Olivier, Lucas, Virginie, Leloup, Rémy, Escoffre, Martine, Colombat, Philippe, Tabuteau, Stéphanie

“…Sixteen patients with aggressive primary testicular involvement were analyzed separately from a prospective multicenter series of 494 patients with stage I/II…”
Get full text